Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.95 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.95 |
| ▸ | HTT | P42858 | 2/20 | 0.95 |
| ▸ | THRB | P10828 | 1/20 | 0.95 |
| ▸ | MAPT | P10636 | 1/20 | 0.95 |
| ▸ | TSHR | P16473 | 3/20 | 0.80 |
| ▸ | USP2 | O75604 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | CES2 | O00748 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.49 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.49 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6138568 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT | |
| SCHEMBL21828760 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT | |
| SCHEMBL344085 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL23356733 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL23356816 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL23356871 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL23356793 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL23356787 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT | |
| SCHEMBL185805 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL2124090 | 1.00 | MEN1 (0.95) | MEN1KMT2AHTTTHRBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12633572-B2 | Electrolytic solution and electrochemical device | MURATA MANUFACTURING CO., LTD. (JP) | 2026-05-19 | — | — | US | disclosed |
| US-12597635-B2 | Electrochemical device | MURATA MANUFACTURING CO., LTD. (JP) | 2026-04-07 | — | — | US | disclosed |
| CN-116918095-A | Positive electrode and electrochemical device | 株式会社村田制作所 | 2023-10-20 | — | — | CN | disclosed |
| CN-116897151-A | Process for producing glycolide | 株式会社吴羽 | 2023-10-17 | — | — | CN | disclosed |
| US-20230231197-A1 | ELECTROLYTIC SOLUTION AND ELECTROCHEMICAL DEVICE | MURATA MANUFACTURING CO., LTD. (JP) | 2023-07-20 | — | — | US | disclosed |
| US-20230223525-A1 | ELECTROCHEMICAL DEVICE | MURATA MANUFACTURING CO., LTD. (JP) | 2023-07-13 | — | — | US | disclosed |
| CN-116250124-A | Electrochemical device | 株式会社村田制作所 | 2023-06-09 | — | — | CN | disclosed |
| CN-111741952-B | Process for producing glycolide | 株式会社吴羽 | 2023-06-09 | — | — | CN | disclosed |
| CN-116210098-A | Electrolyte and electrochemical device | 株式会社村田制作所 | 2023-06-02 | — | — | CN | disclosed |
| WO-2022209595-A1 | POSITIVE ELECTRODE AND ELECTROCHEMICAL DEVICE | 株式会社村田製作所 | 2022-10-06 | — | — | WO | disclosed |
| EP-2377858-B1 | METHOD FOR PRODUCING GLYCOLIDE | KUREHA CORP (JP) | 2014-04-30 | — | — | EP | disclosed |
| US-20120289713-A1 | METHOD FOR PRODUCING GLYCOLIDE | KUREHA CORPORATION (JP) | 2012-11-15 | — | — | US | disclosed |
| US-20110263875-A1 | Production Process of Glycolide | KUREHA CORPORATION (JP) | 2011-10-27 | — | — | US | disclosed |
| EP-2377858-A1 | METHOD FOR PRODUCING GLYCOLIDE | Kureha Corporation (JP) | 2011-10-19 | — | — | EP | disclosed |
| US-7812181-B2 | Process for producing glycolide and glycolic acid oligomer for production of glycolide | KUREHA CORPORATION (JP) | 2010-10-12 | — | — | US | disclosed |
| US-20070293653-A1 | depolymerizing polyglycolic acid by heating in an organic solvent; system is controlled to suppress efffective concentration of impurities (ammonia, amines or amides, methoxyacetic acid and diglycolic acid); high purity glycolide starting material for polyglycolic acid | KUREHA CORPORATION (JP) | 2007-12-20 | — | — | US | disclosed |
| EP-1310496-B1 | PROCESS FOR THE PREPARATION OF CYCLIC ESTERS AND METHOD FOR PURIFICATION OF THE SAME | KUREHA CORP (JP) | 2006-12-06 | — | — | EP | disclosed |
| US-6916939-B2 | Process for the preparation of cyclic esters and method for purification of the same | KUREHA KAGAKU KOGYO K.K. (JP) | 2005-07-12 | — | — | US | disclosed |
| US-20030191326-A1 | Process for the preparation of cyclic esters and method for purification of the same | KUREHA CORPORATION (JP) | 2003-10-09 | — | — | US | disclosed |
| EP-1310496-A1 | PROCESS FOR THE PREPARATION OF CYCLIC ESTERS AND METHOD FOR PURIFICATION OF THE SAME | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2003-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030191326-A1 | Process for the preparation of cyclic esters and method for purification of the same | CEL, CETP, MCCC2 | MEN1 3285/4885KMT2A 3678/4885HTT 4346/4885 |
| US-20110263875-A1 | Production Process of Glycolide | RPN2, RPN1, DDOST | MEN1 4593/4885KMT2A 4858/4885HTT 3742/4885 |
| US-12633572-B2 | Electrolytic solution and electrochemical device | KCNN1, HCN4, KCNN2 | MEN1 801/4885KMT2A 916/4885HTT 3588/4885 |
| US-12597635-B2 | Electrochemical device | CLCN2, HCN4, SLC26A3 | MEN1 1871/4885KMT2A 2323/4885HTT 3183/4885 |
| US-20120289713-A1 | METHOD FOR PRODUCING GLYCOLIDE | DDOST, MAGT1, UGCG | MEN1 2615/4885KMT2A 4626/4885HTT 1229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.